Anzeige
Mehr »
Login
Montag, 23.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Die erste börsennotierte Gesellschaft, die auf das gemeinsame Wachstum von Solana, XRP und Dogecoin setzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 871275 | ISIN: US2394671034 | Ticker-Symbol: DX5
Frankfurt
20.12.24
08:06 Uhr
7,650 Euro
-0,050
-0,65 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
DAXOR CORPORATION Chart 1 Jahr
5-Tage-Chart
DAXOR CORPORATION 5-Tage-Chart

Aktuelle News zur DAXOR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiDaxor Corporation: Daxor Expands Its BVA-100 Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum2
09.10.Daxor Corporation: DAXOR'S INNOVATIVE BVA-100 BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '242
08.10.Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit2
27.09.Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device1
19.09.Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 20241
05.09.Daxor secures $300K from LaunchTN for blood analyzer tech1
04.09.Daxor Corporation: Leading Central Florida Hospital Implements Daxor's BVA-100 Blood Volume Diagnostic for Heart Failure Patient Care1
DAXOR Aktie jetzt für 0€ handeln
03.09.Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter114Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update...
► Artikel lesen
03.09.Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference1
29.08.Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network1
05.08.Daxor Corporation: Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide1
18.07.DAXOR CORP - 8-K, Current Report1
05.06.Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer133Oak Ridge, TN, June 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the appointment of Dr. John L. Jefferies...
► Artikel lesen
25.03.Daxor Corporation Acquires Volumex and Megatope From Its Existing Supplier Along With Glofil to Enhance Existing Suite of Diagnostics187Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology...
► Artikel lesen
18.03.Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders156Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders...
► Artikel lesen
18.03.Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023104Strong Start to 2024 with Unaudited Revenue Climbing 229.1% in First Two Months of 2024 YoY Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in...
► Artikel lesen
12.02.Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions276Oak Ridge, TN, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today announces two significant new customer transactions...
► Artikel lesen
02.01.Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer296The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside Oak Ridge, TN, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1